Short answer
Beauty Health Co (SKIN) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $69M (down 2.1% year over year) with net income of −$888,000.
Q3 2026 key financials · XBRL
- Revenue
- $69M
- −2.1% YoY · −4.1% QoQ
- Net income
- −$888,000
- +91.9% YoY · +66.7% QoQ
- Operating margin
- 7.2%
- Gross margin
- 68.2%
- EPS (diluted)
- −$1.51
- −1577.8% YoY · −7450.0% QoQ
Source: XBRL data from the Beauty Health Co (SKIN) Q3 2026 10-Q on SEC EDGAR. USD.
Beauty Health Co Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $69.2M, down 2.1% YoY from $70.7M
- Gross margin 68.2% vs 64.6% YoY, operating margin 7.2% vs (8.8)%
- Best line Consumables: $50.4M, up 1.2%; weakest Delivery Systems: $18.8M, down 9.9%
- Cash, equivalents and restricted cash $112.4M; nine-month operating cash flow $8.4M vs $22.3M
- Headwinds: macroeconomic and credit conditions, tariffs, geopolitical risks, and $250.0M 2028 Notes requiring refinancing or additional capital
Risk Factors
- Newly added rebranding risk: April 22, 2026 name change may increase marketing costs and weaken customer recognition
- Nasdaq compliance risk: $1.00 bid-price deficiency resolved after October 14, 2026 1-for-20 reverse split
- Delisting risk: another failure within one year could trigger Staff Delisting Determination without a compliance period
- Debt liquidity risk: $250.0 million 2028 Notes exceeded $112.4 million cash, equivalents and restricted cash at September 30, 2026
- Capital markets risk: delisting could trigger 2028 Notes repurchase at principal plus accrued interest
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Beauty Health Co quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.